Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (TCTR20250924003) titled 'The Effects of the Tri-Ka-Tuk Formula on Metabolomics and Proteomics Modifications and Safety in Healthy Participants in Order to Develop Medicine or Supplement' on Sept. 24.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Thailand Science Research and Innovation (TSRI)
Condition:
The study enrolled twelve healthy volunteers.
traditional medicine, untargeted metabolomics, proteomics, LC-MS, piperine, herbal supplementation
traditional medicine, untargeted metabolomics, proteomics, LC-MS, piperine, herbal supplementation
Intervention:
Participants took one 500 mg capsule of TKT orally t...